Current Studies
Enroll Today
Paramount Clinical Research is actively recruiting participants for upcoming studies. If you don't find a suitable study today, please check back regularly for updates on new studies. You may also fill out our general study participant form to be notified about future studies or reach out to us directly at 425-533-0611 to speak with a member of our research team.

Pregnancy & Postpartum Hormone Study
Clinical Study
COMING SOON!
Compensation $125
Now enrolling for a clinical research trial to help evaluate the effectiveness of testing procedures for Beta-Human Chorionic Gonadotropin (Beta-HCG) in women who are in very early or very late pregnancy or postpartum.
Qualifications
-
36+ weeks pregnant
-
OR less than 5 weeks pregnant
-
OR less than 6 weeks postpartum
-
-
Additional criteria may apply

GLP-1 Treatment for COPD
Clinical Research Study
COMING SOON!
Compensation up to $4,500
Now enrolling for a clinical research trial to help evaluate the effectiveness of an investigational GLP-1 therapy vs a placebo on lung function, improvement of COPD symptoms and reduce overall COPD exacerbations in overweight adults with moderate or severe COPD.
Qualifications
-
40-75 years of age
-
Diagnosis of moderate to severe COPD
-
Current or former smoker
-
BMI >25
-
No diagnosis of asthma
-
No Type 1 Diabetes
-
Additional criteria may apply

GLP-1 Treatment for Osteoarthritis of the knee and obesity
Clinical Research Study
COMING SOON!
Now enrolling for a clinical research trial to help evaluate the effectiveness of an investigational GLP-1 therapy vs a placebo on pain, mobility and weight loss in obese adults with osteoarthritis of the knee.
Qualifications
-
18+ years of age
-
Diagnosis of osteoarthritis of the knee
-
BMI >27
-
No diagnosis of Type 1 or Type 2 Diabetes
-
No diagnosis of kidney or liver disease
-
Additional criteria may apply

GLP-1 Treatment For Weight Loss
Clinical Research Study
CLOSED FOR SCREENINGS
Now enrolling for a clinical research trial to help evaluate the effectiveness of an investigational GLP-1 therapy vs a placebo on weight loss in overweight adults.
Qualifications
-
18-75 years of age
-
Body Mass Index > 30 OR
-
Body Mass Index > 27 if also diagnosed with one or more of the following:
-
Hypertension
-
High Cholesterol
-
Cardiovascular Disease
-
Osteoarthritis of the Knee
-
Fatty Liver Disease
-
-
No Type 1 or Type 2 Diabetes
-
Additional criteria may apply
